• PhilPapers
  • PhilPeople
  • PhilArchive
  • PhilEvents
  • PhilJobs
  • Sign in
PhilPeople
 
  • Sign in
  • News Feed
  • Find Philosophers
  • Departments
  • Radar
  • Help
 
profile-cover
Drag to reposition
profile picture

Natalia Montes

University of Washington
  •  Home
  •  Publications
    3
    • Most Recent
    • Most Downloaded
    • Topics
  •  News and Updates
    1

 More details
  • University of Washington
    Department of Philosophy
    Other
Seattle, Washington, United States of America
Areas of Specialization
Neuroethics
Areas of Interest
Social Epistemology
Feminist Philosophy
Personal Identity and Applied Ethics
Moral Psychology
Neuroethics
Business Ethics
Critical Race Theory
Social and Political Philosophy
3 more
  • All publications (3)
  •  477
    Views of stakeholders at risk for dementia about deep brain stimulation for cognition
    with Eran Klein, Ishan Dasgupta, Kate MacDuffie, Andreas Schönau, Garrett Flynn, Dong Song, and Sara Goering
    Brain Stimulation 16 (3): 742-747. 2023.
    Neuroethics, MiscCognitive EnhancementPhilosophy, MiscBiotechnology EthicsTechnology EthicsEngineeri…Read more
    Neuroethics, MiscCognitive EnhancementPhilosophy, MiscBiotechnology EthicsTechnology EthicsEngineering EthicsOther Academic Areas
  •  40
    Asking questions that matter – Question prompt lists as tools for improving the consent process for neurotechnology clinical trials
    with Andreas Schönau, Sara Goering, Erika Versalovic, Tim Brown, Ishan Dasgupta, and Eran Klein
    Frontiers in Human Neuroscience 16. 2022.
    Implantable neurotechnology devices such as Brain Computer Interfaces and Deep Brain Stimulators are an increasing part of treating or exploring potential treatments for neurological and psychiatric disorders. While only a few devices are approved, many promising prospects for future devices are under investigation. The decision to participate in a clinical trial can be challenging, given a variety of risks to be taken into consideration. During the consent process, prospective participants migh…Read more
    Implantable neurotechnology devices such as Brain Computer Interfaces and Deep Brain Stimulators are an increasing part of treating or exploring potential treatments for neurological and psychiatric disorders. While only a few devices are approved, many promising prospects for future devices are under investigation. The decision to participate in a clinical trial can be challenging, given a variety of risks to be taken into consideration. During the consent process, prospective participants might lack the language to consider those risks, feel unprepared, or simply not know what questions to ask. One tool to help empower participants to play a more active role during the consent process is a Question Prompt List. QPLs are communication tools that can prompt participants and patients to articulate potential concerns. They offer a structured list of disease, treatment, or research intervention-specific questions that research participants can use as support for question asking. While QPLs have been studied as tools for improving the consent process during cancer treatment, in this paper, we suggest they would be helpful in neurotechnology research, and offer an example of a QPL as a template for an informed consent tool in neurotechnology device trials.
    Philosophy of NeuroscienceParkinson's DIsease
  •  44
    Integrating Equity Work throughout Bioethics
    with Eran Klein, Erika Versalovic, Andreas Schönau, Darcy McCusker, Timothy Emmanuel Brown, and Sara Goering
    American Journal of Bioethics 22 (1): 26-27. 2022.
    As members of a neuroethics research group funded by the NIH, we echo the call from Fabi and Goldberg for greater funding parity between the ethics of specialized medical technologies and br...
    Biomedical Ethics
PhilPeople logo

On this site

  • Find a philosopher
  • Find a department
  • The Radar
  • Index of professional philosophers
  • Index of departments
  • Help
  • Acknowledgments
  • Careers
  • Contact us
  • Terms and conditions

Brought to you by

  • The PhilPapers Foundation
  • The American Philosophical Association
  • Centre for Digital Philosophy, Western University
PhilPeople is currently in Beta Sponsored by the PhilPapers Foundation and the American Philosophical Association
Feedback